Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, received a suspension order from the Dy. Drugs Controller, Southern Zone, Berhmpur, Odisha. The drug license for one store located at Bahadur Bagicha pada, Odisha has been suspended for five days. The suspension is under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company disclosed a potential revenue loss of Rs 3.80 lakhs due to this suspension. The order was received on April 10, 2026.
The impact on Medplus is minimal as it involves only one store out of the company's broader network, with a relatively small quantified revenue exposure of Rs 3.80 lakhs. This is a routine regulatory compliance matter and unlikely to have material impact on the stock.